Marshall Wace LLP Makes New $256,000 Investment in Electromed, Inc. (NYSE:ELMD)

Marshall Wace LLP acquired a new position in Electromed, Inc. (NYSE:ELMD) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 17,057 shares of the company’s stock, valued at approximately $256,000. Marshall Wace LLP owned 0.20% of Electromed at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Gabelli Funds LLC raised its stake in shares of Electromed by 7.8% during the second quarter. Gabelli Funds LLC now owns 38,675 shares of the company’s stock valued at $581,000 after purchasing an additional 2,808 shares in the last quarter. Aristides Capital LLC increased its stake in Electromed by 22.1% in the 1st quarter. Aristides Capital LLC now owns 24,917 shares of the company’s stock worth $402,000 after purchasing an additional 4,517 shares in the last quarter. Renaissance Technologies LLC increased its stake in Electromed by 4.8% in the 2nd quarter. Renaissance Technologies LLC now owns 103,004 shares of the company’s stock worth $1,548,000 after purchasing an additional 4,736 shares in the last quarter. Hunter Associates Investment Management LLC grew its stake in Electromed by 7.1% during the 1st quarter. Hunter Associates Investment Management LLC now owns 86,200 shares of the company’s stock valued at $1,391,000 after acquiring an additional 5,700 shares in the last quarter. Finally, Vanguard Group Inc. grew its stake in Electromed by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 367,114 shares of the company’s stock valued at $5,929,000 after acquiring an additional 5,886 shares in the last quarter. Institutional investors and hedge funds own 40.82% of the company’s stock.

Electromed Price Performance

NYSE:ELMD opened at $22.67 on Friday. Electromed, Inc. has a fifty-two week low of $9.53 and a fifty-two week high of $22.76. The stock’s 50-day moving average is $17.85 and its two-hundred day moving average is $16.31. The stock has a market cap of $190.43 million, a PE ratio of 39.09 and a beta of 0.27.

Electromed (NYSE:ELMD) last announced its quarterly earnings results on Tuesday, August 27th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.14 by $0.06. The business had revenue of $14.83 million during the quarter. Electromed had a return on equity of 12.44% and a net margin of 9.41%.

Electromed Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.